Cancer BiologyEMBO Molecular MedicinePeer-reviewed
Discovery of oncogenic ROS1 missense mutations with sensitivity to tyrosine kinase inhibitors
S. R. Iyer, K. Nusser, K. Jones…·M. A. Davare
The paper identifies oncogenic ROS1 missense mutations that are sensitive to tyrosine kinase inhibitors, showing their potential as therapeutic targets.
DOI 10.15252/emmm.202217367